DDIT3 and diffuse large B-cell lymphoma: It should be noted that the FLYER trial, which evaluated four versus six cycles of R‐CHOP in patients with stage I‐II DLBCL, was published after enrollment for this trial had begun, therefore early‐stage patients were not considered for an abbreviated course of R‐CHOP.